CLAIM CARD
Mechanistically, the anti-inflammatory rationale for colchicine in inflammaging derives from its capacity to inhibit microtubule polymerization, thereby suppressing NLRP3 inflammasome activation and downstream cytokine release. Shi 2026 provides indirect human observational evidence that this mechanism translates to measurable inflammatory marker reductions in HFpEF, a condition increasingly recognized as inflammation-driven. The mechanistic substrate underlying this functional finding aligns with established pathways of colchicine's action on neutrophil chemotaxis and interleukin-1β processing. Preclinical data on colchicine's anti-inflammatory properties provide the biological plausibility framework, though the current corpus lacks completed RCTs with inflammaging-specific endpoints.
Evidence grade: exploratory
Contradiction status: none
Publication: 873ff54a-3a1e-4c35-b4ff-b2bb5ab68649
Provenance: Derivation Web chain
Citation Support
source_1Mohammadnia 2025source_2Li 2025source_3Ammirati 2026source_4Pascart 2026source_5Broekhoven 2022